Masahide Suzuki Selected Research

Gerstmann Syndrome (Gerstmann's Syndrome)

5/2021

Gerstmann's Syndrome in a Patient Double-positive for Antibodies against the N-methyl-D-aspartate Receptor and NH2-terminal of α-enolase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahide Suzuki Research Topics

Disease

1	Corticobasal Degeneration 01/2022
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Multiple System Atrophy 01/2022
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 05/2021
1	Brain Diseases (Brain Disorder) 05/2021
1	Encephalitis (Encephalitis, Rasmussen) 05/2021
1	Gerstmann Syndrome (Gerstmann's Syndrome) 05/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Gastritis 06/2007

Drug/Important Bio-Agent (IBA)

1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2022
1	Inosine Monophosphate (IMP)IBA 01/2022
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2022
1	AntibodiesIBA 05/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 05/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2021
1	AdiponectinIBA 01/2018

Therapy/Procedure

1	Thymectomy 06/2007